Your browser doesn't support javascript.
loading
Chronic Pseudomonas aeruginosa Lung Infection Is IL-1R Independent, but Relies on MyD88 Signaling.
Mackowiak, Claire; Marchiol, Tiffany; Paljetak, Hana Cipcic; Fauconnier, Louis; Palomo, Jennifer; Secher, Thomas; Panek, Corinne; Sedda, Delphine; Savigny, Florence; Erard, Francois; Bragonzi, Alessandra; Huaux, Francois; Stoeger, Tobias; Schiller, Herbert B; Sirard, Jean-Claude; Le Bert, Marc; Couillin, Isabelle; Quesniaux, Valerie F J; Togbe, Dieudonnée; Ryffel, Bernhard.
Afiliação
  • Mackowiak C; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France.
  • Marchiol T; Artimmune SAS, Orléans, France.
  • Paljetak HC; Center for Translational and Clinical Research, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Fauconnier L; Artimmune SAS, Orléans, France.
  • Palomo J; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France.
  • Secher T; CPER, INSERM, Tours, France.
  • Panek C; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France.
  • Sedda D; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France.
  • Savigny F; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France.
  • Erard F; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France.
  • Bragonzi A; Ospedale San Raffaele, Milan, Italy.
  • Huaux F; ULB, Toxicology, Brussels, Belgium.
  • Stoeger T; Comprehensive Pneumology Center, Institute of Lung Biology and Disease, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg and Member of the German Center for Lung Research, Oberschleißheim, Germany.
  • Schiller HB; Comprehensive Pneumology Center, Institute of Lung Biology and Disease, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg and Member of the German Center for Lung Research, Oberschleißheim, Germany.
  • Sirard JC; Center for Infection and Immunity of Lille, Institute Pasteur and University of Lille, University Hospital Lille, CNRS, INSERM, U1019, UMR8204, Lille, France.
  • Le Bert M; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France.
  • Couillin I; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France.
  • Quesniaux VFJ; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France.
  • Togbe D; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France.
  • Ryffel B; INEM, Experimental and Molecular Immunology and Neurogenetics, University of Orléans, CNRS, UMRP735, Orléans, France bryfffel@cnrs-orleans.fr.
Immunohorizons ; 5(5): 273-283, 2021 05 06.
Article em En | MEDLINE | ID: mdl-33958388
ABSTRACT
Cystic fibrosis is associated with chronic Pseudomonas aeruginosa colonization and inflammation. The role of MyD88, the shared adapter protein of the proinflammatory TLR and IL-1R families, in chronic P. aeruginosa biofilm lung infection is unknown. We report that chronic lung infection with the clinical P. aeruginosa RP73 strain is associated with uncontrolled lung infection in complete MyD88-deficient mice with epithelial damage, inflammation, and rapid death. Then, we investigated whether alveolar or myeloid cells contribute to heightened sensitivity to infection. Using cell-specific, MyD88-deficient mice, we uncover that the MyD88 pathway in myeloid or alveolar epithelial cells is dispensable, suggesting that other cell types may control the high sensitivity of MyD88-deficient mice. By contrast, IL-1R1-deficient mice control chronic P. aeruginosa RP73 infection and IL-1ß Ab blockade did not reduce host resistance. Therefore, the IL-1R1/MyD88 pathway is not involved, but other IL-1R or TLR family members need to be investigated. Our data strongly suggest that IL-1 targeted neutralizing therapies used to treat inflammatory diseases in patients unlikely reduce host resistance to chronic P. aeruginosa infection.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pseudomonas aeruginosa / Infecções por Pseudomonas / Interleucina-1beta / Receptores Tipo I de Interleucina-1 Limite: Animals / Humans Idioma: En Revista: Immunohorizons Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pseudomonas aeruginosa / Infecções por Pseudomonas / Interleucina-1beta / Receptores Tipo I de Interleucina-1 Limite: Animals / Humans Idioma: En Revista: Immunohorizons Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França